Seagen Inc.
ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
Last updated:
Abstract:
Provided are novel anti-.alpha.v.beta.6 antibodies and antibody-drug conjugates and methods of using such anti-.alpha.v.beta.6 antibodies and antibody-drug conjugates to treat cancer.
Status:
Application
Type:
Utility
Filling date:
4 Dec 2020
Issue date:
1 Jul 2021